Prescription medicines: Decision-making preferences of patients who receive different levels of public subsidy

Health Expectations

Volumn 17, Issue 1, 2014, Pages 15-26

  Robertson, Jane ^a   Doran, Evan ^a   Henry, David A ^a,b,c   Salkeld, Glenn ^d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Decision making; Insurance status; Medicines; Patient preferences

Indexed keywords

AGED; ARTICLE; AUSTRALIA; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DECISION MAKING; FEE; FEMALE; HEALTH INSURANCE; HUMAN; INSURANCE; INSURANCE STATUS; MALE; MEDICINES; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT PREFERENCE; PATIENT PREFERENCES; SOCIOECONOMICS; STATISTICS;

DECISION MAKING; INSURANCE STATUS; MEDICINES; PATIENT PREFERENCES;

AGED; AUSTRALIA; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEES, PHARMACEUTICAL; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT PREFERENCE; SOCIOECONOMIC FACTORS;

EID: 84892447436     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/j.1369-7625.2011.00715.x     Document Type: Article

References (24)

1. OECD. Pharmaceutical pricing and reimbursement and the broader pharmaceutical policy environment. Chapter 3. 2008: 85-124 in Pharmaceutical Pricing Policies in a Global Market. Available at: http://fesrvsd.fe.unl.pt/unlfe/monografias/2009/2009-0183.pdf, accessed 27 January 2011.
2. Doran E, Robertson J, Rolfe I, Henry D. Patient co-payments and use of prescription medicines. Australia and New Zealand Journal of Public Health, 2004; 28: 62-67.
3. Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, Semmens J. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiology and Drug Safety, 2008; 17: 1091-1099.
4. Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, Semmens J. Increased patient co-payments and changes in PBS subsidised prescription medicines dispensed in Western Australia. Australian and New Zealand Journal of Public Health, 2009; 33: 246-252.
5. Ampon RD, Reddel HK, Correll PK, Poulos LM, Marks GB. Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease. Medical Journal of Australia, 2009; 191: 319-323.
6. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ, 2000; 320: 1530-1533.
7. Australian Government Department of Health and Ageing. Pharmaceutical Benefits Scheme. Available at: http://www.pbs.gov.au/info/healthpro/explanatory-notes/section1/Section_1_4_Explanatory_Notes, accessed 20 January 2011.
8. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value in Health, 2004; 7: 204-215.
9. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Quality in Health Care, 2001; 10: 135-140.
10. Atkinson MJ, Sinha A, Hass SL et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM) using a national panel study of chronic disease. Health and Quality of Life Outcomes, 2004; 2: 12.
11. Ruiz MA, Pardo A, Rejas J, Soto J, Villasante F, Aranguren JL. Development and Validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q). Value in Health, 2008; 11: 913-926.
12. Holbrook AL, Krosnick JA, Moore D, Tourangeau R. Response order effects in dichotomous categorical questions presented orally: the impact of question and respondent attributes. Public Opinion Quarterly, 2007; 71: 325-348; doi: 10.1093/poq/nfm024.
13. Degnar L, Sloan JA, Venkatesh P. The control preferences scale. Canadian Journal of Nursing Research, 1997; 29: 21-43.
14. SAS Support. Principal component analysis (Chapter 1). Available at: http://support.sas.com/publishing/pubcat/chaps/55129.pdf, accessed 1 June 2007.
15. Australian Health Insurance Association. The demographics of private health insurance. Available at: http://www.independentretirees.com/newsletters/PHI%20Demographics%20Final.pdf, accessed 26 February 2009.
16. Robinson A, Thomson R. Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools. Quality in Health Care, 2001; 10 (Suppl. 1): i34-i38.
17. Schoen C, Osborn R, Huynh PT et al. Taking the pulse of health care systems: experiences of patients with health problems in six countries. Health Affairs, 2005; 24: 509-525.
18. McManus P, Donnelly N, Henry DA, Hall W, Primrose J, Lindner J. Prescription drug utilisation following patient co-payment changes in Australia. Pharmacoepidemiology and Drug Safety, 1996; 5: 385-392.
19. Fallowfield L. Participation of patients in decisions about treatment for cancer. BMJ, 2001; 323: 1144.
20. Levison W, Kao A, Kuby A, Thisted RA. Not all patients want to participate in decision making. Journal of General Internal Medicine, 2005; 20: 531-535.
21. Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients' desire for autonomy: decision making and information seeking preferences among medical patients. Journal of General Internal Medicine, 1989; 4: 23-30.
22. Edwards A, Elwyn G. Inside the black box of shared decision making: distinguishing between the process of involvement and who makes the decision. Health Expectations, 2006; 9: 307-320.
23. Smith SK, Trevena L, Nutbeam D, Dixon A, McCaffery KJ. Exploring patient involvement in healthcare decision making across different education and functional health literacy groups. Social Science and Medicine, 2009; 69: 1805-1812.
24. Flood EM, Beusterien KM, Green H et al. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q™), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women. Health and Quality of Life Outcomes, 2006; 4: 42.